21-37512454-A-T
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 1P and 15B. PP2BP4_ModerateBP6_Very_StrongBS1BS2_Supporting
The NM_001347721.2(DYRK1A):c.2188A>T(p.Met730Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000138 in 1,614,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M730V) has been classified as Likely benign.
Frequency
Consequence
NM_001347721.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYRK1A | NM_001347721.2 | c.2188A>T | p.Met730Leu | missense_variant | 12/12 | ENST00000647188.2 | NP_001334650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYRK1A | ENST00000647188.2 | c.2188A>T | p.Met730Leu | missense_variant | 12/12 | NM_001347721.2 | ENSP00000494572.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251450Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135892
GnomAD4 exome AF: 0.000138 AC: 202AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.000140 AC XY: 102AN XY: 727248
GnomAD4 genome AF: 0.000131 AC: 20AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74378
ClinVar
Submissions by phenotype
DYRK1A-related intellectual disability syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 09, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at